Are Blister Packs Cost-Effective for Cancer Medications?
The cost-effectiveness of blister packs can be a double-edged sword. On one hand, blister packs can be more expensive to produce compared to bulk packaging. However, the benefits in terms of improved medication adherence and reduced wastage can offset these costs. For cancer medications, where the cost of the drug itself is often very high, the added investment in blister packaging can be justified by the potential for better patient outcomes and lower overall healthcare costs.
